Incidence of liver- and non-liver-related outcomes in patients with HCV-cirrhosis after SVR
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Incidence of liver- and non-liver-related outcomes in patients with HCV-cirrhosis after SVR
Authors
Keywords
Hepatitis C Virus, Cirrhosis, DAA, long-term outcome, SVR, events
Journal
JOURNAL OF HEPATOLOGY
Volume 76, Issue 2, Pages 302-310
Publisher
Elsevier BV
Online
2021-09-28
DOI
10.1016/j.jhep.2021.09.013
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment of HCV reduces viral hepatitis-associated liver-related mortality in patients: An ERCHIVES study
- (2020) Adeel Ajwad Butt et al. JOURNAL OF HEPATOLOGY
- DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort
- (2020) Elizabeth C. Verna et al. JOURNAL OF HEPATOLOGY
- Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension
- (2020) Sabela Lens et al. JOURNAL OF HEPATOLOGY
- Occult hepatitis B infection and hepatocellular carcinoma: Epidemiology, virology, hepatocarcinogenesis and clinical significance
- (2020) Lung-Yi Mak et al. JOURNAL OF HEPATOLOGY
- Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity
- (2020) Lisette A.P. Krassenburg et al. JOURNAL OF HEPATOLOGY
- Direct-Acting Antiviral Therapy not Associated with Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study
- (2019) Amit G. Singal et al. GASTROENTEROLOGY
- Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study
- (2019) Fabrice Carrat et al. LANCET
- Update of the statements on biology and clinical impact of occult hepatitis b virus infection
- (2019) Giovanni Raimondo et al. JOURNAL OF HEPATOLOGY
- Real‐world impact following initiation of interferon‐free hepatitis C regimens on liver‐related outcomes and all‐cause mortality among patients with compensated cirrhosis
- (2019) Scott A. McDonald et al. JOURNAL OF VIRAL HEPATITIS
- Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patients
- (2018) Patrice Cacoub et al. AMERICAN HEART JOURNAL
- Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs
- (2018) Pierre Nahon et al. GASTROENTEROLOGY
- Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents
- (2018) Vincenza Calvaruso et al. GASTROENTEROLOGY
- HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma
- (2018) George N. Ioannou et al. JOURNAL OF HEPATOLOGY
- Impact of DAAs on liver transplantation: major effects on the evolution of indications and results. An ELITA study based on the ELTR registry
- (2018) Luca Saverio Belli et al. JOURNAL OF HEPATOLOGY
- EASL Recommendations on Treatment of Hepatitis C 2018
- (2018) Jean-Michel Pawlotsky et al. JOURNAL OF HEPATOLOGY
- Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population study
- (2018) Antonietta Romano et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Persistence of hepatocellular carcinoma risk in hepatitis C patients with a response to IFN and cirrhosis regression
- (2018) Roberta D'Ambrosio et al. LIVER INTERNATIONAL
- Delisting HCV-infected liver transplant candidates who improved after viral eradication: Outcome 2 years after delisting
- (2018) Giovanni Perricone et al. LIVER INTERNATIONAL
- Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection
- (2018) Elisabetta Degasperi et al. Clinical Gastroenterology and Hepatology
- Direct-acting Antiviral Therapy for HCV Infection is Associated with a Reduced Risk of Cardiovascular Disease Events
- (2018) Adeel A. Butt et al. GASTROENTEROLOGY
- Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis
- (2017) Sabela Lens et al. GASTROENTEROLOGY
- Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications
- (2017) Pierre Nahon et al. GASTROENTEROLOGY
- Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents
- (2017) Fasiha Kanwal et al. GASTROENTEROLOGY
- Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry
- (2017) Carlos Fernández Carrillo et al. HEPATOLOGY
- Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication
- (2017) Adriaan J. van der Meer et al. JOURNAL OF HEPATOLOGY
- Direct-acting antivirals: the endgame for hepatitis C?
- (2017) Roberta D’Ambrosio et al. Current Opinion in Virology
- Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension
- (2016) Vito Di Marco et al. GASTROENTEROLOGY
- Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study
- (2016) Luca Saverio Belli et al. JOURNAL OF HEPATOLOGY
- Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension
- (2016) Mattias Mandorfer et al. JOURNAL OF HEPATOLOGY
- Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis
- (2016) Graham R. Foster et al. JOURNAL OF HEPATOLOGY
- Expanding consensus in portal hypertension
- (2015) Roberto de Franchis JOURNAL OF HEPATOLOGY
- EASL Recommendations on Treatment of Hepatitis C 2015
- (2015) JOURNAL OF HEPATOLOGY
- Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
- (2013) Adriaan J. van der Meer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Sustained Viral Response Is Associated With Reduced Liver-Related Morbidity and Mortality in Patients With Hepatitis C Virus
- (2009) Amit G. Singal et al. Clinical Gastroenterology and Hepatology
- Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis
- (2009) Cristina Ripoll et al. JOURNAL OF HEPATOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started